Filtros : "Pharmaceutics" Removidos: "Brasil" "Financiamento FAPEMIG" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 26 set. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 set. 26 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 set. 26 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Source: Pharmaceutics. Unidade: IFSC

    Subjects: STAPHYLOCOCCUS, BIOFILMES, TERAPIA FOTODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALVES, Fernanda et al. Effects on colonization factors and mechanisms involved in antimicrobial sonophotodynamic inactivation mediated by curcumin. Pharmaceutics, v. 15, n. 10, p. 2407-1-2407-18 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15102407. Acesso em: 26 set. 2024.
    • APA

      Alves, F., Pratavieira, S., Inada, N. M., Patiño, C. P. B., & Kurachi, C. (2023). Effects on colonization factors and mechanisms involved in antimicrobial sonophotodynamic inactivation mediated by curcumin. Pharmaceutics, 15( 10), 2407-1-2407-18 + supplementary materials. doi:10.3390/pharmaceutics15102407
    • NLM

      Alves F, Pratavieira S, Inada NM, Patiño CPB, Kurachi C. Effects on colonization factors and mechanisms involved in antimicrobial sonophotodynamic inactivation mediated by curcumin [Internet]. Pharmaceutics. 2023 ; 15( 10): 2407-1-2407-18 + supplementary materials.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15102407
    • Vancouver

      Alves F, Pratavieira S, Inada NM, Patiño CPB, Kurachi C. Effects on colonization factors and mechanisms involved in antimicrobial sonophotodynamic inactivation mediated by curcumin [Internet]. Pharmaceutics. 2023 ; 15( 10): 2407-1-2407-18 + supplementary materials.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15102407
  • Source: Pharmaceutics. Unidades: FCF, IQ

    Subjects: ESPECTROSCOPIA, NANOPARTÍCULAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      EULÁLIO, Denise et al. Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides. Pharmaceutics, v. 15, p. 1-25 art. 955, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15030955. Acesso em: 26 set. 2024.
    • APA

      Eulálio, D., Figueiredo, M. P., Gueho, C. T., Leroux, F., Serra, C. H. dos R., Faria, D. L. A. de, & Constantino, V. R. L. (2023). Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides. Pharmaceutics, 15, 1-25 art. 955. doi:10.3390/pharmaceutics15030955
    • NLM

      Eulálio D, Figueiredo MP, Gueho CT, Leroux F, Serra CH dos R, Faria DLA de, Constantino VRL. Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides [Internet]. Pharmaceutics. 2023 ; 15 1-25 art. 955.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15030955
    • Vancouver

      Eulálio D, Figueiredo MP, Gueho CT, Leroux F, Serra CH dos R, Faria DLA de, Constantino VRL. Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides [Internet]. Pharmaceutics. 2023 ; 15 1-25 art. 955.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15030955
  • Source: Pharmaceutics. Unidade: ICB

    Subjects: MICROBIOLOGIA, PROTEÍNAS, PROTEÍNAS RECOMBINANTES, MEDICAMENTO, NANOPARTÍCULAS, AMINOÁCIDOS, POLIPEPTÍDEOS, GLICOPROTEÍNAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CORCHERO, José Luis et al. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041197. Acesso em: 26 set. 2024.
    • APA

      Corchero, J. L., Favaro, M. T. P., Márquez-Martínez, M., Lascorz, J., Martínez-Torró, C., Sánchez, J. M., et al. (2023). Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, 15( 4), 1-16. doi:10.3390/pharmaceutics15041197
    • NLM

      Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15041197
    • Vancouver

      Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15041197
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ÓLEOS ESSENCIAIS, COMPOSTOS VOLÁTEIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELEM, Bruna Rodrigues et al. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, v. 15, p. 1-23 art. 2564, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112564. Acesso em: 26 set. 2024.
    • APA

      Belem, B. R., Carapeto, G. V., Issa, M. G., & Ferraz, H. G. (2023). Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, 15, 1-23 art. 2564. doi:10.3390/pharmaceutics15112564
    • NLM

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 set. 26 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
    • Vancouver

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 set. 26 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 26 set. 2024.
    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532
    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 set. 26 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 set. 26 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
  • Source: Pharmaceutics. Unidade: ICB

    Subjects: PARASITOLOGIA, ANIMAIS PARASITOS, EXTRATOS (FORMAS FARMACÊUTICAS), PRODUTOS NATURAIS, ANTIMALÁRICOS, PLASMODIUM, PLASMODIUM FALCIPARUM, PLANTAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIBEIRO, Giovane de Jesus Gomes et al. Plant extracts as a source of natural products with potential antimalarial effects: an update from 2018 to 2022. Pharmaceutics, v. 15, n. 6, p. 19 , 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15061638. Acesso em: 26 set. 2024.
    • APA

      Ribeiro, G. de J. G., Yan, S. L. R., Palmisano, G., & Wrenger, C. (2023). Plant extracts as a source of natural products with potential antimalarial effects: an update from 2018 to 2022. Pharmaceutics, 15( 6), 19 . doi:10.3390/pharmaceutics15061638
    • NLM

      Ribeiro G de JG, Yan SLR, Palmisano G, Wrenger C. Plant extracts as a source of natural products with potential antimalarial effects: an update from 2018 to 2022 [Internet]. Pharmaceutics. 2023 ; 15( 6): 19 .[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15061638
    • Vancouver

      Ribeiro G de JG, Yan SLR, Palmisano G, Wrenger C. Plant extracts as a source of natural products with potential antimalarial effects: an update from 2018 to 2022 [Internet]. Pharmaceutics. 2023 ; 15( 6): 19 .[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15061638
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: INFLAMAÇÃO, GANHO DE PESO, RESISTÊNCIA À INSULINA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA, Edson Mendes de et al. Acute inflammation Is a predisposing factor for weight gain and insulin resistance. Pharmaceutics, v. 14, p. 1-13 art. 623, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14030623. Acesso em: 26 set. 2024.
    • APA

      Oliveira, E. M. de, Silva, J. C., Ascar, T. P., Sandri, S., Marchi, A. F., Migliorini, S., et al. (2022). Acute inflammation Is a predisposing factor for weight gain and insulin resistance. Pharmaceutics, 14, 1-13 art. 623. doi:10.3390/pharmaceutics14030623
    • NLM

      Oliveira EM de, Silva JC, Ascar TP, Sandri S, Marchi AF, Migliorini S, Nakaya HTI, Fock RA, Campa A. Acute inflammation Is a predisposing factor for weight gain and insulin resistance [Internet]. Pharmaceutics. 2022 ; 14 1-13 art. 623.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14030623
    • Vancouver

      Oliveira EM de, Silva JC, Ascar TP, Sandri S, Marchi AF, Migliorini S, Nakaya HTI, Fock RA, Campa A. Acute inflammation Is a predisposing factor for weight gain and insulin resistance [Internet]. Pharmaceutics. 2022 ; 14 1-13 art. 623.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14030623
  • Source: Pharmaceutics. Unidades: FCF, IF, ESALQ

    Subjects: FÁRMACOS, LEUCEMIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GUIMARÃES, Marina de Souza et al. Peg-grafted liposomes for L-asparaginase encapsulation. Pharmaceutics, v. 14, n. 9, p. 1-18, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14091819. Acesso em: 26 set. 2024.
    • APA

      Guimarães, M. de S., Cachumba, J. J. M., Bueno, C. Z., Obreque, K. M. T., Lara, G. V. R., Monteiro, G., et al. (2022). Peg-grafted liposomes for L-asparaginase encapsulation. Pharmaceutics, 14( 9), 1-18. doi:10.3390/pharmaceutics14091819
    • NLM

      Guimarães M de S, Cachumba JJM, Bueno CZ, Obreque KMT, Lara GVR, Monteiro G, Barbosa LRS, Pessoa Junior A, Rangel-Yagui C de O. Peg-grafted liposomes for L-asparaginase encapsulation [Internet]. Pharmaceutics. 2022 ; 14( 9): 1-18.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14091819
    • Vancouver

      Guimarães M de S, Cachumba JJM, Bueno CZ, Obreque KMT, Lara GVR, Monteiro G, Barbosa LRS, Pessoa Junior A, Rangel-Yagui C de O. Peg-grafted liposomes for L-asparaginase encapsulation [Internet]. Pharmaceutics. 2022 ; 14( 9): 1-18.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14091819
  • Source: Pharmaceutics. Unidade: FCFRP

    Subjects: ÓLEOS ESSENCIAIS, NANOPARTÍCULAS, CANDIDA, COVID-19, ANTIFÚNGICOS, LAMIALES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BALDIM, Iara et al. Nanostructured lipid carriers loaded with lippia sidoides essential oil as a strategy to combat the multidrug-resistant Candida auris. Pharmaceutics, v. 14, n. 1, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14010180. Acesso em: 26 set. 2024.
    • APA

      Baldim, I., Paziani, M. H., Barião, P. H. G., Kress, M. R. von Z., & Oliveira, W. P. de. (2022). Nanostructured lipid carriers loaded with lippia sidoides essential oil as a strategy to combat the multidrug-resistant Candida auris. Pharmaceutics, 14( 1), 1-13. doi:10.3390/pharmaceutics14010180
    • NLM

      Baldim I, Paziani MH, Barião PHG, Kress MR von Z, Oliveira WP de. Nanostructured lipid carriers loaded with lippia sidoides essential oil as a strategy to combat the multidrug-resistant Candida auris [Internet]. Pharmaceutics. 2022 ; 14( 1): 1-13.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14010180
    • Vancouver

      Baldim I, Paziani MH, Barião PHG, Kress MR von Z, Oliveira WP de. Nanostructured lipid carriers loaded with lippia sidoides essential oil as a strategy to combat the multidrug-resistant Candida auris [Internet]. Pharmaceutics. 2022 ; 14( 1): 1-13.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14010180
  • Source: Pharmaceutics. Unidade: IQ

    Subjects: NANOPARTÍCULAS, PEPTÍDEOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PÉREZ-BETANCOURT, Yunys et al. Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer. Pharmaceutics, v. 14, p. 1-18 art. 2053, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102053. Acesso em: 26 set. 2024.
    • APA

      Pérez-Betancourt, Y., Zaia, R., Evangelista, M. F., Ribeiro, R. T., Roncoleta, B. M., Mathiazzi, B. I., & Carmona-Ribeiro, A. M. (2022). Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer. Pharmaceutics, 14, 1-18 art. 2053. doi:10.3390/pharmaceutics14102053
    • NLM

      Pérez-Betancourt Y, Zaia R, Evangelista MF, Ribeiro RT, Roncoleta BM, Mathiazzi BI, Carmona-Ribeiro AM. Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer [Internet]. Pharmaceutics. 2022 ; 14 1-18 art. 2053.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14102053
    • Vancouver

      Pérez-Betancourt Y, Zaia R, Evangelista MF, Ribeiro RT, Roncoleta BM, Mathiazzi BI, Carmona-Ribeiro AM. Characterization and differential cytotoxicity of gramicidin nanoparticles combined with cationic polymer or lipid bilayer [Internet]. Pharmaceutics. 2022 ; 14 1-18 art. 2053.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14102053
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, MEDICAMENTO, BIOEQUIVALÊNCIA, FORMAS FARMACÊUTICAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ISSA, Michele Georges et al. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, v. 14, p. 1-21 art. 892, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050892. Acesso em: 26 set. 2024.
    • APA

      Issa, M. G., Souza, N. V. de, Jou, B. W. C., Duque, M. D., & Ferraz, H. G. (2022). Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, 14, 1-21 art. 892. doi:10.3390/pharmaceutics14050892
    • NLM

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
    • Vancouver

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
  • Source: Pharmaceutics. Unidades: FCFRP, FMRP

    Subjects: DERMATITE, PRODUTOS NATURAIS, PRÓPOLIS, HIPERSENSIBILIDADE, CREME

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTIN, Bianca Aparecida et al. A new approach to atopic dermatitis control with low-concentration propolis-loaded cold cream. Pharmaceutics, v. 13, n. 9, p. 1-22, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13091346. Acesso em: 26 set. 2024.
    • APA

      Martin, B. A., Lemos, C. N., Dalmolin, L. F., Arruda, C., Brait, Í. S. C., Cazarim, M. de S., et al. (2021). A new approach to atopic dermatitis control with low-concentration propolis-loaded cold cream. Pharmaceutics, 13( 9), 1-22. doi:10.3390/pharmaceutics13091346
    • NLM

      Martin BA, Lemos CN, Dalmolin LF, Arruda C, Brait ÍSC, Cazarim M de S, Cazarim ELC da C, Bueno PCP, Polizello Júnior M, Pereira LRL, Cardili RN, Lopez RFV. A new approach to atopic dermatitis control with low-concentration propolis-loaded cold cream [Internet]. Pharmaceutics. 2021 ; 13( 9): 1-22.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics13091346
    • Vancouver

      Martin BA, Lemos CN, Dalmolin LF, Arruda C, Brait ÍSC, Cazarim M de S, Cazarim ELC da C, Bueno PCP, Polizello Júnior M, Pereira LRL, Cardili RN, Lopez RFV. A new approach to atopic dermatitis control with low-concentration propolis-loaded cold cream [Internet]. Pharmaceutics. 2021 ; 13( 9): 1-22.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics13091346
  • Source: Pharmaceutics. Unidades: IQ, FCF

    Subjects: SURFACTANTES, NANOPARTÍCULAS, METILMETACRILATOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MATHIAZZI, Beatriz Ideriha e CARMONA-RIBEIRO, Ana Maria. Hybrid nanoparticles of poly (methyl methacrylate) and antimicrobial quaternary ammonium surfactants. Pharmaceutics, v. 12, n. 4, p. 1-20 art. 340, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12040340. Acesso em: 26 set. 2024.
    • APA

      Mathiazzi, B. I., & Carmona-Ribeiro, A. M. (2020). Hybrid nanoparticles of poly (methyl methacrylate) and antimicrobial quaternary ammonium surfactants. Pharmaceutics, 12( 4), 1-20 art. 340. doi:10.3390/pharmaceutics12040340
    • NLM

      Mathiazzi BI, Carmona-Ribeiro AM. Hybrid nanoparticles of poly (methyl methacrylate) and antimicrobial quaternary ammonium surfactants [Internet]. Pharmaceutics. 2020 ; 12( 4): 1-20 art. 340.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12040340
    • Vancouver

      Mathiazzi BI, Carmona-Ribeiro AM. Hybrid nanoparticles of poly (methyl methacrylate) and antimicrobial quaternary ammonium surfactants [Internet]. Pharmaceutics. 2020 ; 12( 4): 1-20 art. 340.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12040340
  • Source: Pharmaceutics. Unidade: IQ

    Subjects: PELE, FERRO, FERIMENTOS E LESÕES, CICATRIZAÇÃO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FIGUEIREDO, Mariana Pires et al. Polymer/iron-based layered double hydroxides as multifunctional wound dressings. Pharmaceutics, v. 12, p. 1-18 art. 1130, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12111130. Acesso em: 26 set. 2024.
    • APA

      Figueiredo, M. P., Sánchez, A. B., Villén, F. G., Miele, D., Rossi, S., Sandri, G., et al. (2020). Polymer/iron-based layered double hydroxides as multifunctional wound dressings. Pharmaceutics, 12, 1-18 art. 1130. doi:10.3390/pharmaceutics12111130
    • NLM

      Figueiredo MP, Sánchez AB, Villén FG, Miele D, Rossi S, Sandri G, Viseras C, Constantino VRL. Polymer/iron-based layered double hydroxides as multifunctional wound dressings [Internet]. Pharmaceutics. 2020 ; 12 1-18 art. 1130.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12111130
    • Vancouver

      Figueiredo MP, Sánchez AB, Villén FG, Miele D, Rossi S, Sandri G, Viseras C, Constantino VRL. Polymer/iron-based layered double hydroxides as multifunctional wound dressings [Internet]. Pharmaceutics. 2020 ; 12 1-18 art. 1130.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12111130
  • Source: Pharmaceutics. Unidades: FCF, IQ, FCFRP

    Subjects: ANTIOXIDANTES, METABOLISMO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAVARES, Renata Spagolla Napoleão et al. Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism. Pharmaceutics, v. 12, n. 2, p. 1-12 art. 136, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12020136. Acesso em: 26 set. 2024.
    • APA

      Tavares, R. S. N., Maria-Engler, S. S., Colepicolo, P., Debonsi, H. M., Schäfer-Korting, M., Marx, U., et al. (2020). Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism. Pharmaceutics, 12( 2), 1-12 art. 136. doi:10.3390/pharmaceutics12020136
    • NLM

      Tavares RSN, Maria-Engler SS, Colepicolo P, Debonsi HM, Schäfer-Korting M, Marx U, Gaspar LR, Zoschke C. Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism [Internet]. Pharmaceutics. 2020 ; 12( 2): 1-12 art. 136.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12020136
    • Vancouver

      Tavares RSN, Maria-Engler SS, Colepicolo P, Debonsi HM, Schäfer-Korting M, Marx U, Gaspar LR, Zoschke C. Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism [Internet]. Pharmaceutics. 2020 ; 12( 2): 1-12 art. 136.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12020136
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, v. 12, p. 1-17 art, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12050420. Acesso em: 26 set. 2024.
    • APA

      Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2020). Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, 12, 1-17 art. doi:10.3390/pharmaceutics12050420
    • NLM

      Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
    • Vancouver

      Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
  • Source: Pharmaceutics. Unidade: FCFRP

    Subjects: CLOREXIDINA, BIOFILMES, STREPTOCOCCUS MUTANS, AGENTES ANTIMICROBIANOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RÉ, Ana Carolina dos Santos et al. Effect of an experimental formulation containing chlorhexidine on pathogenic biofilms and drug release behavior in the presence or absence of bacteria. Pharmaceutics, v. 11, n. 2, p. [9] , 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11020088. Acesso em: 26 set. 2024.
    • APA

      Ré, A. C. dos S., Bonjovanni, M. C., Duarte, M. P. F., Freitas, O. de, & Garbellini, C. P. A. (2019). Effect of an experimental formulation containing chlorhexidine on pathogenic biofilms and drug release behavior in the presence or absence of bacteria. Pharmaceutics, 11( 2), [9] . doi:10.3390/pharmaceutics11020088
    • NLM

      Ré AC dos S, Bonjovanni MC, Duarte MPF, Freitas O de, Garbellini CPA. Effect of an experimental formulation containing chlorhexidine on pathogenic biofilms and drug release behavior in the presence or absence of bacteria [Internet]. Pharmaceutics. 2019 ; 11( 2): [9] .[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics11020088
    • Vancouver

      Ré AC dos S, Bonjovanni MC, Duarte MPF, Freitas O de, Garbellini CPA. Effect of an experimental formulation containing chlorhexidine on pathogenic biofilms and drug release behavior in the presence or absence of bacteria [Internet]. Pharmaceutics. 2019 ; 11( 2): [9] .[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics11020088
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: PRÓPOLIS, POLIFENÓIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OYARZO, Dina Guzmán et al. Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis. Pharmaceutics, v. 11, p. 1-17 art. 289, 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11060289. Acesso em: 26 set. 2024.
    • APA

      Oyarzo, D. G., Plaza, T., Sánchez, G. R., Abdalla, D. S. P., Salazar, L. A., & Montelongo, J. H. (2019). Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis. Pharmaceutics, 11, 1-17 art. 289. doi:10.3390/pharmaceutics11060289
    • NLM

      Oyarzo DG, Plaza T, Sánchez GR, Abdalla DSP, Salazar LA, Montelongo JH. Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis [Internet]. Pharmaceutics. 2019 ; 11 1-17 art. 289.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics11060289
    • Vancouver

      Oyarzo DG, Plaza T, Sánchez GR, Abdalla DSP, Salazar LA, Montelongo JH. Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis [Internet]. Pharmaceutics. 2019 ; 11 1-17 art. 289.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics11060289
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, v. 11, p. 1-12 art. 215, 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11050215. Acesso em: 26 set. 2024.
    • APA

      Duque, M. D., Silva, D. A., Issa, M. G., Porta, V., Löbenberg, R., & Ferraz, H. G. (2019). In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation. Pharmaceutics, 11, 1-12 art. 215. doi:10.3390/pharmaceutics11050215
    • NLM

      Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics11050215
    • Vancouver

      Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. In silico prediction of plasma concentrations of Fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation [Internet]. Pharmaceutics. 2019 ; 11 1-12 art. 215.[citado 2024 set. 26 ] Available from: https://doi.org/10.3390/pharmaceutics11050215

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024